CD5 and B-cell chronic lymphocytic leukemia: Fazi et al. reported on 76 patients with LC-MBL and observed that, after a median follow-up time of 34 months, 90% of the cases persisted over time in contrast to only 44.4% and 66.7% of atypical CLL and CD5(−) MBL, respectively [33].